glp 1 and iron absorption Low GLP-1 Medications – Active Iron On a GLP-1?, GLP-1 medications

Patients taking insulin or sulfonylureas alongside Ozempic should seek advice about dose adjustments if experiencing reduced food intake due to gastrointestinal symptoms, as the risk of hypoglycaemia may increase in these circumstances

WeightWatchers has conducted a 6-month clinical trial of 180 participants on GLP-1 medication (Heinberg et al.), but the manuscript is under review and has not yet been published in a peer-reviewed journal

However, when the landmark trials of semaglutide (STEP 1) and tirzepatide (SURMOUNT-1) measured body composition, they found that in some analyses, around 40% of weight loss came from LBM

Patients with established cardiovascular disease Those with previous myocardial infarction, stroke, or peripheral arterial disease may benefit from the cardioprotective effects of certain GLP-1 receptor agonists, which include modest blood pressure reductions alongside other cardiovascular benefits

Other insulin-sensitizing treatments can complement these options for a more tailored approach

This finding underscores the importance of clinical physicians being aware of and conducting comprehensive patient history assessments before prescribing these medications